ST-617 HEAD and NECK
18 Nov 2020
ST 617-101
ACTRN12620000541909
A Phase 1b, Multicenter Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of ST-617 for the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for Head and Neck Cancer
Supportive Therapeutics (Pty) Ltd
Cancer Type | Head and Neck |
---|---|
Trial Type | Treatment |
Phase | Phase I; Phase II |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | Head and Neck |
Cancer Stage | All stages |
Anticipated Start Date | 2019-11-12 |
Anticipated End Date | n/a |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Hannah Adelson |
Hannah.adelson@sa.gov.au | |
Phone | 08 8206 4835 |
Principal Investigator | Dr Shawgi Sukumaran |
Recruitment Status | Recruitment on Hold |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Dr Hien Le |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs